Product
STAR-001
BIOTECHNOLOGY
byStarlight Therapeutics
United States (US)
ABOUT THE PRODUCT
STAR-001 is Starlight Therapeutics’ lead drug candidate, a novel therapeutic agent being developed for the treatment of CNS cancers, including glioblastoma, brain metastases, and ATRT.
Information is owner-confirmed
Last updated 2 months ago
Price range